Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
PCPG | rs72797767 | chr16:71606716 | A/C | 1.08E-5 | 174 | 25 | 30.93 | 14.5 | KM Plot |
PCPG | rs72797770 | chr16:71609054 | C/T | 1.09E-5 | 174 | 24.85 | 30.93 | 14.5 | KM Plot |
PCPG | rs72797773 | chr16:71609457 | C/G | 1.0E-5 | 175 | 24.7 | 30.93 | 14.5 | KM Plot |
PCPG | rs72797783 | chr16:71615370 | A/G | 9.47E-6 | 176 | 24.47 | 30.93 | 14.5 | KM Plot |
PCPG | rs72797794 | chr16:71625620 | G/A | 1.09E-5 | 174 | 25 | 30.93 | 14.5 | KM Plot |
PCPG | rs72799868 | chr16:71688544 | C/T | 1.07E-5 | 173 | 24.85 | 34.47 | 14.5 | KM Plot |
PCPG | rs72799894 | chr16:71707388 | G/A | 8.79E-6 | 175 | 24.23 | 31.48 | 14.5 | KM Plot |
PCPG | rs72801717 | chr16:71737164 | T/C | 9.25E-6 | 175 | 23.83 | 32.03 | 14.5 | KM Plot |
PCPG | rs72801722 | chr16:71745709 | G/A | 9.75E-6 | 175 | 24.47 | 32.03 | 14.5 | KM Plot |
PCPG | rs72801729 | chr16:71759672 | A/G | 8.74E-6 | 176 | 24.23 | 30.93 | 14.5 | KM Plot |
PCPG | rs72809466 | chr16:88676975 | C/T | 0.000342 | 176 | 25.53 | 24.35 | 14.47 | KM Plot |
PCPG | rs72811447 | chr2:61426155 | A/G | 7.06E-5 | 177 | 21.95 | 30.63 | 10.3 | KM Plot |
PCPG | rs72811450 | chr2:61427030 | G/C | 6.7E-5 | 177 | 23.77 | 31.48 | 10.3 | KM Plot |
PCPG | rs72811458 | chr2:61440552 | G/A | 7.05E-5 | 176 | 24.1 | 31.48 | 10.3 | KM Plot |
PCPG | rs72811463 | chr2:61467894 | A/G | 6.95E-5 | 177 | 23.43 | 30.93 | 10.3 | KM Plot |